Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Balk

Showing results (91-100 of 189) with videos related to

Pageof 19
Sort By:
Nature|May 27, 2016
Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapyZhenfei Li, Mohammad Alyamani, Jianneng Li, et al.
Oncotarget|December 5, 2015
Protein phosphatase 1 suppresses androgen receptor ubiquitylation and degradationXiaming Liu, Weiwei Han, Sarah Gulla, et al.
Molecular Cancer Therapeutics|June 19, 2024
AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate CancerMannan Nouri, Andreas Varkaris, Maya Ridinger, et al.
The Journal of Biological Chemistry|December 30, 2004
Recruitment of the androgen receptor via serum response factor facilitates expression of a myogenic geneSpiros Vlahopoulos, Warren E Zimmer, Guido Jenster, et al.
Experimental Hematology|February 12, 2008
Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: implications for posttransplant survivalAngela Shaulov, Simon Yue, Ruojie Wang, et al.
Cancer Cell|October 22, 2011
Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1Changmeng Cai, Housheng Hansen He, Sen Chen, et al.
BJU International|April 11, 2008
A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormonesMary-Ellen Taplin, Judith Manola, William K Oh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2002
CD1d and invariant NKT cells at the human maternal-fetal interfaceJonathan E Boyson, Basya Rybalov, Louise A Koopman, et al.
Nucleic Acids Research|January 8, 2017
Positive feedback loop mediated by protein phosphatase 1α mobilization of P-TEFb and basal CDK1 drives androgen receptor in prostate cancerXiaming Liu, Yanfei Gao, HuiHui Ye, et al.
Molecular Cancer Therapeutics|March 21, 2025
Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient CellsMaryam Labaf, Wanting Han, Songqi Zhang, et al.
Pageof 19

Showing results (91-100 of 189) with videos related to

Sort By:
Pageof 19
Nature|May 27, 2016
Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapyZhenfei Li, Mohammad Alyamani, Jianneng Li, et al.
Oncotarget|December 5, 2015
Protein phosphatase 1 suppresses androgen receptor ubiquitylation and degradationXiaming Liu, Weiwei Han, Sarah Gulla, et al.
Molecular Cancer Therapeutics|June 19, 2024
AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate CancerMannan Nouri, Andreas Varkaris, Maya Ridinger, et al.
The Journal of Biological Chemistry|December 30, 2004
Recruitment of the androgen receptor via serum response factor facilitates expression of a myogenic geneSpiros Vlahopoulos, Warren E Zimmer, Guido Jenster, et al.
Experimental Hematology|February 12, 2008
Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: implications for posttransplant survivalAngela Shaulov, Simon Yue, Ruojie Wang, et al.
Cancer Cell|October 22, 2011
Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1Changmeng Cai, Housheng Hansen He, Sen Chen, et al.
BJU International|April 11, 2008
A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormonesMary-Ellen Taplin, Judith Manola, William K Oh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2002
CD1d and invariant NKT cells at the human maternal-fetal interfaceJonathan E Boyson, Basya Rybalov, Louise A Koopman, et al.
Nucleic Acids Research|January 8, 2017
Positive feedback loop mediated by protein phosphatase 1α mobilization of P-TEFb and basal CDK1 drives androgen receptor in prostate cancerXiaming Liu, Yanfei Gao, HuiHui Ye, et al.
Molecular Cancer Therapeutics|March 21, 2025
Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient CellsMaryam Labaf, Wanting Han, Songqi Zhang, et al.
Pageof 19